EMAIL THIS PAGE TO A FRIEND

Oncotarget

NDRG4 is a novel oncogenic protein and p53 associated regulator of apoptosis in malignant meningioma cells.


PMID 26053091

Abstract

Aggressive meningiomas exhibit high levels of recurrence, morbidity and mortality. When surgical and radiation options are exhausted, there is need for novel molecularly-targeted therapies. We have recently identified NDRG4 overexpression in aggressive meningiomas. NDRG4 is a member of the N-Myc Downstream Regulated Gene (NDRG) family of the alpha/beta hydrolase superfamily. We have demonstrated that NDRG4 downregulation results in decreased cell proliferation, migration and invasion. In follow up to our prior studies; here we demonstrate that the predominant form of cell death following NDRG4 silencing is apoptosis, utilizing Annexin-V flow cytometry assay. We show that apoptosis caused by p53 upregulation, phosphorylation at Ser15, BAX activation, Bcl-2 and BcL-xL downregulation, mitochondrial cytochrome c release and execution of caspases following NDRG4 depletion. Sub-cellular distribution of BAX and cytochrome c indicated mitochondrial-mediated apoptosis. In addition, we carried out the fluorescence cytochemical analysis to confirm mitochondrial-mediated apoptosis by changes in mitochondrial membrane potential (Ψm), using JC-1 dye. Immunoprecipitation and immunofluorescence confirmed binding of NDRG4 to p53. In addition, we demonstrate that apoptosis is mitochondrial and p53 dependent. The proapoptotic effect of p53 was verified by the results in which a small molecule compound PFT-α, an inhibitor of p53 phosphorylation, is greatly protected against targeting NDRG4 induced apoptosis. These findings bring novel insight to the roles of NDRG4 in meningioma progression. A better understanding of this pathway and its role in meningioma carcinogenesis and cell biology is promising for the development of novel therapeutic targets for the management of aggressive meningiomas.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB1405552
Anti-CAMK4 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
HPA011753
Anti-CAMK4 antibody produced in rabbit, Ab2, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
HPA017206
Anti-CAMK4 antibody produced in rabbit, Ab1, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
AV37025
Anti-CAMK4 antibody produced in rabbit, IgG fraction of antiserum
SAB4503233
Anti-CAMK4 antibody produced in rabbit, affinity isolated antibody
HPA015313
Anti-NDRG4 antibody produced in rabbit, Ab1, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
HPA017587
Anti-NDRG4 antibody produced in rabbit, Ab2, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB4502796
Anti-NDRG4 antibody produced in rabbit, affinity isolated antibody
AV49121
Anti-ST6GALNAC4 antibody produced in rabbit, affinity isolated antibody
SAB2701445
Anti-ST6GALNAC4 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
WH0000814M1
Monoclonal Anti-CAMK4 antibody produced in mouse, clone 1A3, purified immunoglobulin, buffered aqueous solution
WH0065009M1
Monoclonal Anti-NDRG4 antibody produced in mouse, clone 2G3, purified immunoglobulin, buffered aqueous solution